Parkinson’s Disease With Neurogenic Orthostatic Hypotension

PARKINSON’S DZ WITH IDIOPATHIC ORTHOSTATIC HYPOTENSION

Lundbeck NOH 402 RESTORE: A clinical study of patients with Parkinson’s Disease with symptomatic neuRogenic orthostatic hypotEnsion to assess Sustained effecTs Of dRoxidopa thErapy

  • PI:  ANDREA HALLER, MD
  • CONTACT MINDY
  • Duration 36 week study
  • Phase 4 study

KEY INCLUSION CRITERIA

  • *Age 18 and older
  • *Orthostatic hypotension with PD, MSA or PAF
  • *Drop of 20 mmHg in SBP                 .

KEY EXCLUSION CRITERIA

  • Alcohol or drug abuse
  • BP systolic > 180 diastolic > 110
  • Hx of MI or stroke within 2 years.